Subscribe to our Newsletters !!

    Kumar Jeetendra

    myUpchar starts delivering Hospital Supplies for Health workers

    Personal protective equipment (PPE) protects healthcare workers and caregivers who come in contact with COVID-19 patients again and again, and for prolonged periods. Globally, there is a shortage of this equipment as healthcare systems in many countries are under unprecedented strain because of the new coronavirus infection. Seeing the shortage of PPE equipment in several

    Let us know some facts about Coronavirus

    It was post-dinner time on Saturday 4th April 2020; the 12th evening of lock-down in India. Mr.Madhav was sitting in front of his laptop eagerly waiting for the bell of 10 pm on Web meeting. He and his close friends Kiran, Avinash, Santosh, Suhas, Mahesh, Rajan, Seema, Kavya, Vidya, Geetanjali and Namrata from different places

    Sanofi and Regeneron downsize Kevzara’s COVID-19 test

    Accomplices Sanofi (Euronext: SAN) and Regeneron Pharmaceuticals (Nasdaq: REGN) have reported that – following a survey by the Independent Data Monitoring Committee (IDMC) – its examination deal with Kevzara (sarilumab) in COVID-19 will be downsized. The organizations have declared the starter results from the Phase II part of a continuous Phase II/III preliminary assessing the

    Could the world have a coronavirus immunization by September?

    A coronavirus immunization is one bit nearer because of promising outcomes following testing on monkeys – with across the board accessibility to conceivably come as ahead of schedule as September. Six rhesus macaque monkeys were infused with a portion of the Oxford University researchers’ antibody and remain contamination free a month subsequent to being presented

    China lab rejects COVID-19 frame claims, yet infection roots still a secret

    SHANGHAI Claims that the coronavirus pandemic began in a research facility in the Chinese city of Wuhan have no premise actually, the leader of the lab told Reuters, including that there were still no indisputable answers with regards to where the sickness began. Connivance scholars have guaranteed SARS-CoV-2, presently liable for in excess of 200,000

    Natco Pharma’s’ gets USFDA endorsement for Visakhapatnam plant

    Natco Pharma today declared that it has gotten a last endorsement for its first supplemental condensed new medication application (ANDA) item from US Food and Drug Administration (USFDA) documented from its new medication plan office in JNPC SEZ, Ramky Pharma City, Visakhapatnam (Andhra Pradesh). ANDA, submitted as ‘earlier endorsement supplement’, accommodates NATCO’s Visakhapatnam office as

    Roche says risdiplam viable in spinal muscular atrophy preliminary

    Roche Holding AG’s risdiplam showed significant improvement in survival and motor milestones in a clinical trial for infants with type 1 spinal muscular atrophy (SMA), the Swiss drugmaker said on Tuesday. The Firefish part 2 study met its primary endpoint by demonstrating a significant increase in motor milestones in infants aged 1-7 months after 12

    Hydroxychloroquine to be given to Health workers treating COVID-19 patients

    Healthcare workers associated with the treatment of coronavirus patients will be given hydroxychloroquine (HCQ) tablets as a preventive prescription, the Maharashtra government has said and given rules on the utilization of the medication. State Health secretary Pradeep Vyas in an ongoing round said the medication will be given to specialists, attendants and clinical staff engaged

    COVID-19 could prompt 7 million unintended pregnancies as access to contraceptives upset: UN study

    Progressing lockdowns and significant interruptions to wellbeing administrations during the COVID-19 pandemic could leave 47 million ladies in low and center salary nations incapable to utilize present day contraceptives, prompting 7,000,000 unintended pregnancies in the coming months, as per information discharged by the UN Population Fund (UNFPA) and accomplices. The offices gauge that the quantity

    Strides Pharma creates medication to battle Covid-19

    Strides Pharma Science Limited, a worldwide pharmaceutical organization on Wednesday said it has created and marketed Favipiravir antiviral tablets which were discovered successful to battle Covid-19 disease. The item is a conventional variant of Avigan of Toyama Chemical, Japan. Favipiravir is an antiviral drug that was at first evolved to treat flu in Japan. In